How Does The Medicine, Tarceva, Impact Cancer When Chemotherapy Has Failed?
My husband has lung and bone cancer,has had chemo treatments,they are not working any more,the cancer is growing more and quite fast.Our doctor is putting him on Tarceva,will this pill help him?He sleeps alot now.What exactly can we expect from this pill?
Tarceva is also called erlotinib . It is used for initial treatment for patients with NSCLC whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations as first line treatment. It can be also be used as maintenance treatment for advanced-stage NSCLC in patients whose cancer has not spread or grown after prior treatment with certain types of chemotherapy. Tarceva can also be used 2nd- or 3rd-line treatment for advanced-stage NSCLC in patients whose cancer has spread or grown after receiving at least one round of chemotherapy. Tarceva is not meant to be used at the same time as certain types of chemotherapy for advanced NSCLC. For initial treatment of patients with NSCLC whose cancer has spread to other parts of the body, it is not known if Tarceva is safe and effective in other EGFR mutations. Major side effects from this pill is rash and diarrhea. Regards DR De
I find this answer helpful
You found this answer helpful
Note: For further queries related to kidney problems Click here.
Disclaimer: These answers are for your information only and not intended to replace your relationship with your treating physician.
This is a short, free answer.
For a more detailed, immediate answer, try our premium service
[Sample answer]
We use cookies in order to offer you most relevant experience and using this website you acknowledge that you have already read and understood our
Privacy Policy
How Does The Medicine, Tarceva, Impact Cancer When Chemotherapy Has Failed?
Tarceva is also called erlotinib . It is used for initial treatment for patients with NSCLC whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations as first line treatment. It can be also be used as maintenance treatment for advanced-stage NSCLC in patients whose cancer has not spread or grown after prior treatment with certain types of chemotherapy. Tarceva can also be used 2nd- or 3rd-line treatment for advanced-stage NSCLC in patients whose cancer has spread or grown after receiving at least one round of chemotherapy. Tarceva is not meant to be used at the same time as certain types of chemotherapy for advanced NSCLC. For initial treatment of patients with NSCLC whose cancer has spread to other parts of the body, it is not known if Tarceva is safe and effective in other EGFR mutations. Major side effects from this pill is rash and diarrhea. Regards DR De